BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 5, 2026
Company
Compass Therapeutics, Inc. (CMPX)
Other upcoming events for CMPX
Phase 3 Readout
Phase 3 Topline: A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel
Dec 1, 2026
Phase 3 Readout
Phase 3 Topline: A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel
Dec 1, 2026
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
CMPX Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — CMPX Earnings Report | BioSniper